These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6815548)

  • 1. The benzodiazepine antagonist, Ro 15-1788, prevents the effects of flurazepam on the high pressure neurological syndrome.
    Bichard AR; Little HJ
    Neuropharmacology; 1982 Sep; 21(9):877-80. PubMed ID: 6815548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of flurazepam convulsive threshold by Ro 15-1788.
    Bourn WM; Garrett RL; Reigel CE; Risinger FO
    Psychopharmacology (Berl); 1985; 85(3):267-70. PubMed ID: 3923513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs that increase gamma-aminobutyric acid transmission protect against the high pressure neurological syndrome.
    Bichard AR; Little HJ
    Br J Pharmacol; 1982 Jul; 76(3):447-52. PubMed ID: 6286024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of benzodiazepine agonists, inverse agonists and Ro 15-1788 on the responses of the superior cervical ganglion to GABA in vitro.
    Little HJ
    Br J Pharmacol; 1984 Sep; 83(1):57-68. PubMed ID: 6091828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A benzodiazepine agonist and contragonist have hypothermic effects in rodents.
    Taylor SC; Little HJ; Nutt DJ; Sellars N
    Neuropharmacology; 1985 Jan; 24(1):69-73. PubMed ID: 3920546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the benzodiazepine antagonist Ro 15-1788 after "general anaesthetic" doses of benzodiazepines in mice.
    Little HJ; Bichard AR
    Br J Anaesth; 1984 Oct; 56(10):1153-60. PubMed ID: 6148095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of adenosine accumulation by a CNS benzodiazepine antagonist (Ro 15-1788) and a peripheral benzodiazepine receptor ligand (Ro 05-4864).
    Morgan PF; Lloyd HG; Stone TW
    Neurosci Lett; 1983 Oct; 41(1-2):183-8. PubMed ID: 6417576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788.
    Kubota K; Sugaya K; Matsuda I; Matsuoka Y; Terawaki Y
    Jpn J Pharmacol; 1985 Jan; 37(1):101-5. PubMed ID: 2859382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the benzodiazepine receptor antagonist Ro 15-1788 on the anticonvulsant and anticonflict actions of MK-801.
    Clineschmidt BV
    Eur J Pharmacol; 1982 Oct; 84(1-2):119-21. PubMed ID: 6814930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of benzodiazepines on single unit activity in the substantia nigra pars reticulata.
    Ross RJ; Waszczak BL; Lee EK; Walters JR
    Life Sci; 1982 Sep; 31(10):1025-35. PubMed ID: 6813614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Ro 15-1788 to investigate the benzodiazepine receptor in vivo: studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663.
    Green AR; Nutt DJ; Cowen PJ
    Psychopharmacology (Berl); 1982; 78(3):293-5. PubMed ID: 6296905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benzodiazepine antagonist, Ro 15-1788 does not decrease ethanol withdrawal convulsions in rats.
    Little HJ; Taylor SC; Nutt DJ; Cowen PJ
    Eur J Pharmacol; 1985 Jan; 107(3):375-7. PubMed ID: 3920059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of seizures elicited by the benzodiazepine Ro 5-3663--a comparison with picrotoxin.
    File SE
    J Pharm Pharmacol; 1984 Dec; 36(12):837-40. PubMed ID: 6151978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of 3-carbomethoxy-beta-carboline induced seizures by diazepam and the benzodiazepine antagonists, Ro 15-1788 and CGS 8216.
    Schweri M; Cain M; Cook J; Paul S; Skolnick P
    Pharmacol Biochem Behav; 1982 Sep; 17(3):457-60. PubMed ID: 6815667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure response to Ro15-1788, a benzodiazepine antagonist.
    Rosenberg HC; Chiu TH
    Life Sci; 1985 Feb; 36(8):781-7. PubMed ID: 3919233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepine agonist-type activity of raubasine, a rauwolfia serpentina alkaloid.
    Charveron M; Assié MB; Stenger A; Briley M
    Eur J Pharmacol; 1984 Nov; 106(2):313-7. PubMed ID: 6099274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antagonist-induced benzodiazepine abstinence syndrome.
    Rosenberg HC; Chiu TH
    Eur J Pharmacol; 1982 Jun; 81(1):153-7. PubMed ID: 6811290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo interactions between the benzodiazepine antagonist Ro 15-1788 and the steroid anaesthetic althesin in rats.
    Wardley-Smith B; Little HJ
    Br J Anaesth; 1985 Jun; 57(6):629-33. PubMed ID: 3924085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788.
    Grecksch G; de Carvalho LP; Venault P; Chapouthier G; Rossier J
    Life Sci; 1983 May; 32(22):2579-84. PubMed ID: 6406779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepine receptor involvement in the control of receptive field size and responsiveness in primary somatosensory cortex.
    Oka JI; Jang EK; Hicks TP
    Brain Res; 1986 Jun; 376(1):194-8. PubMed ID: 3013376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.